Spine Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device byJosh SandbergMarch 3, 2025
Spine Top Stories Spinal Stabilization Technologies Ltd. Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease byJosh SandbergNovember 16, 2022
Regulatory Spine Spinal Stabilization Technologies Ltd Earns CE Mark, FDA “Breakthrough Designation” For PerQdisc Nucleus Replacement System For Degenerative Disc Disease byChris StewartMay 25, 2021
